X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by six weeks. [Read More]
Thumbnail
Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by six weeks. [Read More]
Thumbnail
Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by six weeks. [Read More]
A new $56,000-a-year Alzheimer's drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually. [Read More]
The company said a Food and Drug Administration review concluded the shots remain safe and effective for at least 4 1/2 months. [Read More]
Johnson & Johnson said Thursday that U.S. regulators extended the... [Read More]
A Food and Drug Administration review concluded the shots remain safe and effective up to 4 and a half months. The shots were originally approved... [Read More]
Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by an extra six weeks.... [Read More]
Johnson & Johnson said an FDA review concluded the shots remain safe and effective up to 4 and a half months, up from 3 months. [Read More]
Government health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated... [Read More]
Las autoridades de salud estadounidenses aprobaron el lunes el primer... [Read More]
The FDA is requiring the drugmaker to conduct a follow-up study to confirm benefits for patients. [Read More]
"Very quickly over a period of months it was like the fog was lifted from the top of my head," said Bonham, who is now... [Read More]
"Very quickly over a period of months it was like the fog was lifted from the top of my head," said Bonham, who is now... [Read More]
"Very quickly over a period of months it was like the fog was lifted from the top of my head," said Bonham, who is now... [Read More]
Government health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated... [Read More]
On Monday, Government health officials in the US approved the first new drug for Alzheimer's disease in nearly 20 years. [Read More]
The decision, which could impact millions of older Americans, is certain to spark disagreements among physicians, medical researchers and patient groups. [Read More]
Both the FDA and Medicare are barred from considering cost when reviewing a new drug or treatment. [Read More]
The Food and Drug Administration said it granted approval to the drug from Biogen based on results that seemed "reasonably likely" to benefit Alzheimer's patients. [Read More]
Loading...
Save As
Preview
Preview